Subcellular mislocalization of the transcription factor NF-E2 in erythroid cells discriminates prefibrotic primary

Konrad Aumann1, Anna-Verena Frey, Annette M May

  • 1Institute of Pathology, University Medical Center Freiburg, Freiburg, Germany.

Blood
|May 15, 2013
PubMed

Insights

Nuclear factor erythroid 2 (NF-E2) mislocalization in myeloproliferative neoplasms (MPNs) distinguishes essential thrombocythemia (ET) from primary myelofibrosis (PMF). This finding supports NF-E2 immunohistochemistry as a reliable diagnostic tool for MPN classification.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Pathology

Background:

  • The World Health Organization (WHO) classification categorizes myeloproliferative neoplasms (MPNs) into essential thrombocythemia (ET), primary myelofibrosis (PMF), and MPN, unclassifiable (MPN,U).
  • Distinguishing between ET and early, prefibrotic PMF is clinically significant due to differing prognoses, yet can be diagnostically challenging.
  • Aberrant expression of the transcription factor nuclear factor erythroid 2 (NF-E2) has been previously observed in MPN patients.

Purpose of the Study:

  • To investigate the diagnostic utility of nuclear factor erythroid 2 (NF-E2) localization in differentiating ET from PMF.
  • To establish a quantitative threshold for NF-E2 nuclear localization to support differential diagnosis in MPNs.

Main Methods:

  • Immunohistochemistry was employed to assess NF-E2 localization in bone marrow biopsies from MPN patients.
  • Quantitative analysis of nuclear NF-E2 staining was performed.
  • Statistical analysis, including bootstrapping and interobserver concordance assessment, was utilized to validate findings.

Main Results:

  • Aberrant NF-E2 mislocalization was observed in PMF cells compared to ET cells.
  • A threshold of 20% nuclear NF-E2 staining demonstrated high statistical significance in discriminating between ET and PMF.
  • This NF-E2 staining cutoff achieved 92% accuracy in classifying MPN,U cases upon follow-up and showed high interobserver concordance (Spearman's rho = 0.727).

Conclusions:

  • Quantitative NF-E2 immunohistochemistry is a reliable tool for supporting the differential diagnosis between ET and PMF.
  • NF-E2 mislocalization serves as a significant biomarker for distinguishing these MPN subtypes.
  • This method offers a valuable adjunct to existing diagnostic criteria for MPNs.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...